MedTrace Logo

Ambulatory Cancer Care Electronic Symptom Self-Reporting for Surgical Patients

NCT03178045 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2793

Last updated 2023-06-23

Study results available
· View outcomes & findings →

Summary

The aim of this study is to understand and improve the experience of patients after surgery by comparing two methods of following symptoms while the patient recovers at home.

Conditions

  • Patient Reported Outcomes

Interventions

OTHER

Team Monitoring

In this cohort, the electronic system will provide advanced informatics support for push notifications to the care team based on the severity of the symptoms reported. This platform promotes early detection and intervention. The care team is alerted when patients experience symptoms out of the expected range or if symptoms are worsening. Nurses receive secure message notifications and will contact the patient by phone depending on symptom severity. If a patient responds with a moderate-severe answer, the office team gets an alert and calls the patient during business hours.

OTHER

Enhanced Feedback

In this cohort, the electronic system will provide tailored normative data visualizations that offer context and education to patients regarding expected symptom severity. The information provided to patients in the Enhanced Feedback group will be procedure specific and based on continuously updated PRO-CTCAE data from previous patients. Patients are thus able to see their own recovery trajectory relative to that of patients who have undergone the same procedure. Care is patient activated in that patients will use the information about expected symptoms to decide whether they should call the care team (e.g., if they are experiencing symptoms that are more severe or more prolonged than expected). If a patient reports severe symptoms, they are instructed to immediately contact their physician's office or seek medical attention.

Sponsors & Collaborators

  • Brigham and Women's Hospital

    collaborator OTHER

  • University of Rochester

    collaborator OTHER

  • Weill Medical College of Cornell University

    collaborator OTHER

  • Memorial Sloan Kettering Cancer Center

    lead OTHER

Principal Investigators

  • Robert Allen, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-31
Primary Completion
2019-10-30
Completion
2023-05-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03178045 on ClinicalTrials.gov